Latest Biogen Idec Stories
Editor Note: For more information about this release, please scroll to bottom. NEW YORK, April 9, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts'
Comprehensive cloud-based Clinical Trial Optimization System transforms clinical operations quality and efficiency from startup through closeout with a single unified platform. Newton,
Raleigh Convention Center on April 8th RALEIGH, N.C., April 1, 2014 /PRNewswire/ -- An expected 1000 life science professionals from Pfizer, Biogen Idec, Novartis, GlaxoSmithKline, Novo Nordisk,
DUBLIN, April 1, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5q5tcr/global_orphan) has announced the addition of the "Concise
The Approval of ALPROLIX is First Significant Advance in Hemophilia B Treatment in More Than 17 Years CAMBRIDGE, MA, March 24, 2014 /CNW/ -
DALLAS, March 22, 2014 /PRNewswire/ -- ReportsnReports.com offers "Global Orphan Drug Market Outlook 2018", "Global Orphan Drugs Market 2014-2018" and "Global Orphan Drug
NEW YORK, March 14, 2014 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 100, S&P 500, MidCap 400 and S&P SmallCap 600 indices after the close of trading